Page last updated: 2024-11-01

niceritrol and Impotence

niceritrol has been researched along with Impotence in 1 studies

Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.

Research Excerpts

ExcerptRelevanceReference
"It is recommended for patients with hyperlipemia alone, or those who suffer from combined erectile dysfunction."2.67[The clinical effect of slow releasing nicotinate on hyperlipemic impotent patients]. ( Hwang, TI; Yang, CR, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, TI1
Yang, CR1

Trials

1 trial available for niceritrol and Impotence

ArticleYear
[The clinical effect of slow releasing nicotinate on hyperlipemic impotent patients].
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1993, Volume: 52, Issue:4

    Topics: Delayed-Action Preparations; Erectile Dysfunction; Humans; Hyperlipidemias; Male; Niceritrol; Single

1993